Last week, the Cuban Center for Molecular Immunology, or CIM, announced a major health breakthrough with VAXIRA, a vaccine treatment for lung cancer. This is a remarkable achievement, made only more impressive by the fact that this is Cuba’s second lung cancer vaccine.

The vaccine stops the progression of cancer by developing the patient’s immune system to fight off cancer cells. This has proven to significantly prolong people’s survival. Since 2013, the vaccine has been monitored, trialed, and tested on more than 1,300 patients. Over a 10-year period, patients survived a median of 76.6 months, with 20% of all patients who were given VAXIRA experiencing unexpected long-term survival. Last year, VAXIRA was awarded the Technological Innovation Prize in Cuba for its contribution to healthcare in Cuba. This is an incredible feat for humanity and the battle against cancer—and it is being done by a country facing the longest and most severe blockade in history.

In 2011, Cuba developed CIMAvax, which remains the world’s only approved lung cancer vaccine. This vaccine works to induce the immune system to stop the growth of cancer cells and slow the progression of tumors. This vaccine has already treated more than 5,000 people across the world and many more thousands in Cuba itself. Given the immense significance of the vaccine, the United States agreed to a special arrangement to trial the vaccine in the US. The Roswell Park Cancer Institute in New York has been running clinical trials with CIM since 2018. They have run the first clinical trials of CIMAvax in the United States. The very same nation that is imposing a genocidal blockade on Cuba is also benefiting from the historic breakthroughs in healthcare.

These major developments in medicine to treat cancer are not Cuba’s only awe-inspiring health achievements.

The truth is that even with this genocidal blockade, Cuba maintains the principles of its revolution and the motivation to better the world.

During the Covid-19 pandemic, Cuba produced five vaccines: Ablada, Soberana 01, Soberana 02, Soberana Plus, and Mambisa. Cuba had one of the lowest Covid-19 deaths in the Western Hemisphere—and by 2021, Cuba’s fatality rate was just 0.59% compared with the 2.2% worldwide average. The vaccines were produced without the need for specialist refrigeration, which meant they could be easily transported and also distributed across the world to places where accessing such infrastructure would be impossible. Quickly, Venezuela, Iran, Vietnam, St. Vincent and the Grenadines, and Mexico all picked up the vaccine to protect their population.

By 2023, Cuba had the third-highest rate of vaccinations per 100,000 people. Despite the fact that the US banned the country from importing the syringes necessary to immunize its own population. In this context, Cuba was the first country in the world to vaccinate toddlers and children, as part of their push to reopen schools safely.

Cuba, like the United States, offered its Covid-19 vaccines to the world. While Cuba donated vaccines to St. Vincent and the Grenadines and sold them as cheaply as they could, the US bullied countries into putting up their assets, like embassy buildings and military bases, in order to access vaccines. This was to “protect” against future legal challenges that vaccine recipients might file against the manufacturer of the vaccine. This profit motive was a major cause for the vaccine apartheid in the distribution of Covid-19 protection across the world. As of August 2024, in high-income countries, more than 222 doses had been distributed per 100 people. While in low-income countries, this was less than 46. In 2021, US pharmaceutical companies that produced Covid-19 vaccines (Moderna, Pfizer, Johnson & Johnson) collected an eye-watering revenue of $31 billion. The concept that companies and shareholders should make money from a pandemic should be utterly outrageous.

Cuba leads the world in its vaccine breakthroughs. But, how is this all possible? It is not by accident that Cuba is able to develop world-leading health breakthroughs in medicine. Cuba has developed a world-class biotechnological sector that is state-owned and operates in the interests of the people, not profit. There are no profit motives to producing vaccines; research and development are for the collective benefit, and resources are shared to better the process of scientific development. This is quite the opposite situation in capitalist countries, where biotechnology is a major competition dominated by pharmaceutical companies motivated entirely by profits, which often means that when there are major developments in health, they are not accessible to people.

In 1981, Cuba opened the Biological Research Center, despite the blockade stopping the entry of equipment, materials, access to research journals, and medicines. In the first 9 years, the center produced three products. Between 1990 and 2000, it produced 18, and between 2001 and 2010, it produced more than 40. Today, that figure continues to grow. The center flourished into a world-class biotechnological sector that has made major health breakthroughs. Cuba produced the world’s first human vaccine to contain a synthetic antigen for Haemophilus influenzae type B.

In 1989, Cuba produced the world’s first Meningitis B vaccine during a severe outbreak of the disease in the country. This was the first ever vaccine produced to protect against Meningitis B and was exported to protect people in countries across Latin America. The US approved its first vaccine for Meningitis B in 2014.

Cuba once had among the lowest rates of infant mortality in the world. But since 2019, with the increase of more than 250 additional sanctions on Cuba, the rates of infant mortality have risen by 148%.

The following year, Cuba produced a vaccine for Hepatitis B. They joined just five other countries as a manufacturer of Hep B vaccines: France, South Korea, the United States, Indonesia, and........

© Common Dreams